Centene Financial Insights Q2 2025

Centene Q2 2025: $0.16 loss despite 18% revenue rise. High Medicaid/ACA costs push MLR up; pivot to margin recovery, exits & 2026 repricing.
Centene Q2 2025: $0.16 loss despite 18% revenue rise. High Medicaid/ACA costs push MLR up; pivot to margin recovery, exits & 2026 repricing.
This website uses cookies to ensure you get the best experience on our website.